|
Rovere G, Nadal-Nicolás FM, Wang J, Bernal-Garro JM, García-Carrillo N, Villegas-Pérez MP, Agudo-Barriuso M, Vidal-Sanz M. Melanopsin-Containing or Non-Melanopsin-Containing Retinal Ganglion Cells Response to Acute Ocular Hypertension With or Without Brain-Derived Neurotrophic Factor Neuroprotection. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6652-6661. doi: 10.1167/iovs.16-20146. PubMed PMID: 27930778.
AÑO: 2016; IF: 3.303
|
27930778
|
Nadal-Nicolás FM, Rodriguez-Villagra E, Bravo-Osuna I, Sobrado-Calvo P, Molina-Martínez I, Villegas-Pérez MP, Vidal-Sanz M, Agudo-Barriuso M, Herrero-Vanrell R. Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1183-92. doi: 10.1167/iovs.15-18213. PubMed PMID: 26975030.
AÑO: 2016; IF: 3.303
|
|
Di Pierdomenico J, García-Ayuso D, Jiménez-López M, Agudo-Barriuso M, Vidal-Sanz M, Villegas-Pérez MP. Different Ipsi- and Contralateral Glial Responses to Anti-VEGF and Triamcinolone Intravitreal Injections in Rats. Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3533-44. doi: 10.1167/iovs.16-19618. PubMed PMID: 27379578.
AÑO: 2016; IF: 3.303
|
|
Madeira MH, Ortin-Martinez A, Nadal-Nícolas F, Ambrósio AF, Vidal-Sanz M, Agudo-Barriuso M, Santiago AR. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Sci Rep. 2016 Jun 8;6:27532. doi: 10.1038/srep27532. PubMed PMID: 27270337; PubMed Central PMCID: PMC4897621.
AÑO: 2016; IF: 4.259
|
|
Hadj-Saïd W, Froger N, Ivkovic I, Jiménez-López M, Dubus É, Dégardin-Chicaud J, Simonutti M, Quénol C, Neveux N, Villegas-Pérez MP, Agudo-Barriuso M, Vidal-Sanz M, Sahel JA, Picaud S, García-Ayuso D. Quantitative and Topographical Analysis of the Losses of Cone Photoreceptors and Retinal Ganglion Cells Under Taurine Depletion. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4692-703. doi: 10.1167/iovs.16-19535. PubMed PMID: 27607415.
AÑO: 2016; IF: 3.303
|